Zhitong Finance App News, China Heart Link Chemical (01866) issued an announcement. After considering the opinions put forward by the Hong Kong Stock Exchange Limited (SEHK) on Mr. Chen's independence, and based on prudential compliance and ensuring continued compliance with the Hong Kong Stock Exchange Limited Securities Listing Rules (Listing Rules) requirements relating to directors' independence, the board of directors has decided to reassign Chen Weixian (Mr. Chan) from an independent non-executive director to a non-executive director (reassignment) from July 22, 2026.

Mr. Chen has been an independent non-executive director of the Company, a member of the Board's Audit Committee and Nomination Committee, and the Chairman of the Board's Remuneration Committee since June 23, 2026. Mr. Chen will serve as a non-executive director of the Company from the effective date of the reassignment.

As of July 22, 2026, Mr. Chan will no longer serve as Chairman of the Remuneration Committee and a member of the Nomination Committee, but will continue to be a member of the Audit Committee and a member of the Remuneration Committee.

Mr. Li Hongxing, the current independent non-executive director, was appointed as Chairman of the Remuneration Committee with effect from July 22, 2026. Following the above changes, the composition of the Remuneration Committee will comply with the relevant requirements of the listing rules.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.